Marijuana for Parkinson’s Patient

Last year, news broke that the greater part of British MPs is supporting a call to authorize weed for medical use. Presently, numerous clients are approaching to voice support for the measure. One such supporter and patient, 55-year old Ian Frizell, took to YouTube to show how cannabis has significantly helped and enhanced his life. You can see this video by clicking the youtube button.


Frizell experiences Parkinson’s Disease, which causes alarming side effects, for example, full-body tremors and Dystonia, which makes the muscles in his foot twist over, getting to be plainly unusable. Frizell clarifies that not long ago, he experienced stimulation surgery to embed a medical gadget that covers the impacts of Parkinson’s.

Frizell said he needed to show how even a little measurements of medicinal pot takes brisk and constructive outcomes on his condition. To start with, he quit taking his doctor prescribed medicine, and killed his brain stimulation device.

Ian clarified that “What you are seeing here is my Parkinson’s tremor with positively no pharmaceutical at all. I can’t endure the professionally prescribed medicine for Parkinson’s disease. They make me feel to a greatly unwell”.

Frizell also explained that his Dystonia had lessoned considerably and his voice was stronger, making it easier to get words out.

You can read the whole story Here

Medicinal Marijuana for Parkinson’s Disease

Medical Marijuana’s profound effects on Parkinson’s disease.  This man takes Medical Marijuana for the first time to treat Parkinson’s. The results are incredible.

The endocannabinoid system is located in the brain and made up of cannabinoid receptors (a receptor is molecular switch on the outside of a cell that makes something happen inside a cell when activated) that are linked to neurons (brain cells) that regulate thinking and some body functions.

Cannabis As Medicine: January 15 Infographic


There are discussions happening daily across America as to the efficacy of cannabis as medicine. People that refuse to see the truth are simply not looking at the facts, or the thousands of studies that have occurred worldwide confirming that it is very effective for a wide variety of ailments.

Most states that have legal medical marijuana have opted for a list of ailments that can be treated by this amazing plant, and the restrictions on its application and use are not based in science, but fear. Even the “smoking” aspect of cannabis has shown to not be as detrimental as once thought.

By Habit 420

Oregon Cannabis Connection


Marijuana Differences, Indica and Sativa


All medical cannabis is not the same. There are a wide number of varieties coming from many areas of the world. These varieties are called ‘strains.’ Different strains have different traits. This is important to consider in terms of cannabis used for medicinal purposes. The specific characteristics of different cannabis strains give them unique properties that have the potential to benefit those with differing illnesses and conditions. In other words, one strain may work well for someone who is suffering from a neurological disorder while another will provide greater benefits for someone with PTSD.

A July 10, 2014, article in the Los Angeles Times refers to 779 strains on file. Whether that total is up to date or not, clearly, there are too many strains for us to reasonably discuss them all here. Instead, we’ll focus on an overview of strains and their parent types.

The wide variety of strains are generally traced back to the following subspecies of cannabis:

  • Sativas
  • Indicas Hazes
  • Ruderalis

Pure Sativa

This variety of the cannabis plant grows the tallest, reaching heights of 20 feet, but is difficult to cultivate. They primarily grow in Equatorial regions, such as Colombia, Mexico and Southeast Asia. The plants are thin, with narrow leaves that are light green in color. It can take as many as 16 weeks for a Sativa plant to reach maturity.

Their flavors are often described as sweet, fruity and/or earthy. In their pure form, they can cause paranoia among users and irregular heartbeats. Some have described the same hyper sensation someone may feel if they’ve had too much caffeine. On the other hand, thy can provide relief from depression, fatigue, pain, nausea or an overactive appetite.

Pure Indica

Pure Indica is a shorter, denser plant with broad leaves and darker green in color. They originally came from the central Asian region of Afghanistan, Pakistan and Tibet. They generally mature within 8 weeks. They also grow well indoors.

They can also have sweet and fruity flavors but some have a strong and unsavory aroma. They can help fight pain and insomnia. They have powerful sedative properties.


Ruderalis originates in Russia and has very low levels of THC (tetrahydrocannabinol). However, it is a very hearty plant and has a very high level of CBD (cannabidiol). Rather than flowering based on seasons, it flowers according to its age, which is called autoflowering. Crossbreeding with sativas and indicas can produce autoflowering hybrids with the medicinal benefits of those plants.


By crossbreeding different varieties of cannabis, developers have created strains that have a wide range of medicinal benefits. Continued efforts to refine these strains have resulted in newer strains that have greater potential for growers and end users who seek the healing and pain-relieving traits of medical cannabis. The strains come in a plethora of colorful names, from Charlotte’s Web and Girl Scout Cookies to Strawberry Cough and Bubba Kush. Whatever the name, the different strains have varied benefits that offer great promise for those with different illnesses and conditions.

Crossbreeding different varieties of cannabis strains develop hybrids. Hybrids are created to take advantage of traits found in different strains and to increase or limit the characteristics of those strains. In this way, developers can create strains that retain or increase positive medicinal benefits while reducing or eliminating unwanted side effects. They can also create strains that have positive attributes with an ability to grow faster.

The indicas and sativas are the types of cannabis most commonly grown. The prior is generally found in the tallest cannabis plants. Ruderalis is typically the shortest. Ruderalis also, typically, has the lowest levels of tetrahydrocannabinol (THC) and can flower in seasons when the other types are generally dormant. Therefore, by crossbreeding a sativas or indicas with a ruderalis, developers hope to create a more effective hybrid with a longer growing cycle.

Sativas and Indicas have higher ratios of THC to cannabidiol (CBD) – 200:1, on average. While higher THC levels may increase a strain’s appeal among recreational users of cannabis, it doesn’t necessarily provide greater medicinal benefits. For this reasons, strains of sativas and indicas have been developed that focus on their medical benefits even if, and sometimes because, they have lower THC to CBD ratios.

THC is the chemical compound that creates a high with the use of cannabis. CBD, on the other hand, does not come with a high for the user. Still, this isn’t to say that, medicinally, we want THC-free cannabis. Cannabis with THC can also have distinct medicinal benefits. And, together, THC and CBD can create a potent medicinal cocktail

The actual names of different strains vary. What is most important is the genotype and environment of the cannabis plant and the amount of THC vs CBD each strain contains.  Remember that all cannabinoids, whether psychoactive or not, can provide major medical benefits to patients who need them.

consider the strains of medical cannabis


Article Source:

The Healing Clinic (February, 16 2017) Under Health & Wellness

Theres No Known Cure For Arthritis But Cannabis Can Help

There’s No Known Cure For Arthritis, But Marijuana Works Wonders

Featured Image Description: “Theres No Known Cure For Arthritis But Cannabis Can Help” Photo by Imani Clovis via Unsplash

More than 50 million Americans suffer from this painful. debilitating condition.


Here’s some good news: Medical marijuana is helping people with arthritis improve their quality of life. Most of us know someone — an aunt, uncle or grandmother — suffering from arthritis. It is one of the most common health ailments in the world, with more than 50 million people affected in the U.S. alone.

The term “arthritis” is actually a category that includes over 100 conditions and diseases affecting joints and surrounding tissue. Symptoms of pain, stiffness and swelling aching joints are common. Arthritis can seem inescapable and changes people’s quality of life. There is no known cure.

Despite anecdotal evidence about efficacy of marijuana for arthritis, physicians simply don’t know enough about it to engage their patients about it as a treatment option. In one study, 70 percent of physicians said they would not know how to discuss possible interactions with other meds or suggest dose.

That is a great shame since cannabis has a better safety profile than the NSAIDS, steroids and opiates that are often employed to reduce arthritis discomfort but come with increased risk of heart attack, stroke, weakening of bones and addiction. Even if patients were able to use cannabis as a complementary therapy, they could very potentially cut back on the use of harder, more dangerous meds.

It’s no surprise that cannabis could offer arthritis sufferers relief. After all, cannabis is known to be as much as 20 times more effective than aspirin at reducing inflammation and can be an effective sleep aid. Some research certainly supports those decisions.

An Israeli study found that 90 percent of medical marijuana patients stayed on their medicine regimen and most reported reduced pain and function. Researchers at the University of Nottingham noted that targeting cannabinoid receptors with medical marijuana products may help bring pain relief to knee joint pain associated with osteoarthritis.

The first Health Canada approved cannabis clinical trial studying arthritis began in 2016. The CAPRI Trial (Cannabinoid Profile Investigation of Vaporized Cannabis in Patients with Osteoarthritis of the Knee) will compare the effects of different ratios of THC and CBD as well as the short term safety of vaporized cannabis. Results have not yet been published.

Similar to other ailments, a gap exists between physician knowledge base about cannabis and patient interest. Some patients and physicians will wait until there is irrefutable evidence before trying cannabis as an alternative therapy. Others will not wait for more information and seek to improve their quality of life with cannabis now.

What we do know is that as more states come online with regulated medical marijuana, more patients will have an alternative to consider, and having options is good news.


Article Source: 

The Fresh Toast (April 04, 2017) by Trey Reckling

Cancer Blood Test

Teenager dying of cancer ‘recovers after mother gives him marijuana’

Scientists have called for further research into the effect of cannabis compounds on cancer cells after a teenage boy who was given the drug by his mother survived the disease.

Callie Blackwell said she decided to give cannabis to her son Deryn, who was suffering from a rare, aggressive form of leukaemia, to ease his pain and anxiety as he lay dying in a hospice.

After unsuccessfully requesting a prescription for a cannabis-based painkiller from a doctor, Ms Blackwell and her husband Simon met a dealer in a service station to buy some cannabis, which they prepared at home in a pressure cooker using instructions found online.

“I thought: ‘what have I got to lose? He’s dying anyway’. The effects of it blew my mind. It wasn’t what I expected,” Ms Blackwell told ITV’s This Morning.

Ms Blackwell said she expected 14-year-old Deryn, who had undergone multiple rounds of chemotherapy and radiotherapy following his diagnosis at the age of 10, to die when doctors said nothing else could be done.

But Deryn, who is now 17, made a gradual recovery and is now studying catering and has a part-time job as a vegan chef.

Cancer experts have warned stories like Deryn’s cannot prove the efficacy of one treatment over another until properly controlled clinical trials have taken place.

“There have been lots of studies looking at the effect of cannabis on cells growing in the lab, but that’s been quite mixed, it seems to have had different effects on different types of cancer cells,” said Emma Smith, science information manager for Cancer Research UK.

Deryn Blackwell during his cancer treatment (Twitter / @_doeverything)

Dr Smith told The Independent Deryn’s recovery was “wonderful news”, but said: “It could have been a number of things. Perhaps cannabis did help, perhaps it didn’t.

“Because it’s just one person’s story, without a doctor analysing all the clinical evidence and comparing him to somebody that didn’t get cannabis, we still don’t know for certain it was the cannabis that helped him.”

Wai Liu, a senior cancer research fellow at St George’s University of London, has led research into the potential anti-cancer properties of chemicals found in cannabis such as cannabidiol (CBD) and tetrahydrocannabinol (THC).

“I try and separate the science from clinical studies from anecdotal evidence, but there are certain compounds in cannabis, namely CBD and THC, which in a laboratory are anti-cancer in effect,” he said.

“There’s no two ways about it. What it does to certain cancer cells is precisely the same thing as drug companies are trying to develop.

“But the difficulty is always translating what we see in clinical and animal studies into what we see in humans.”

Dr Liu told The Independent he often received reports based on anecdotal evidence of people who self-prescribe cannabis.

“Some patients are getting the benefit, but I don’t know if it’s due to the drug or something else, because it’s not controlled,” he said.

“There’s something in it worth exploring, and that’s what a number of scientists are trying to do.”

Peter McCormick, a cellular neuroscience and biology researcher at the University of Surrey, said Deryn’s case was “very heartening” and “validates that we need more research into what is going on”.

“There are such stories, not his but others, where benefits have been seen. There are others where it hasn’t worked, so the bottom line is we need more research to understand what’s in play here.”

Oxford University recently announced a new £10m research programme into the medical use of marijuana. Scientists will explore the potential benefits of cannabis compounds in an attempt to create new treatments for conditions including pain, cancer and inflammatory diseases.

Zameel Cader, associate professor in clinical neurosciences, said the medical use of marijuana was an “area of huge untapped potential” – but the Home Office has said there are no plans to make the “harmful drug” legal.

Currently there is one licenced cannabis-based medicine in Britain, designed to reduce muscle spasms in people with multiple sclerosis (MS).

The mouth spray, called Sativex, contains two chemical extracts taken from the cannabis plant.

It was licenced for use in the UK in 2010, but is not usually available on the NHS in England as it is deemed too expensive. It is, however, available to MS patients in Wales.

A clinical trial into Sativex last month showed improvement in patients with a certain form of brain cancer when combined with another drug.

“It is a positive result, we’ll have to wait for bigger trials to be carried out, but it does suggest that at least for brain tumours, there is some promise of benefit to treating people with a cannabis extract, in this case Sativex,” said Dr Smith.

By GFarma News